📰 Nasdaq Pcsa News
Nasdaq Pcsa News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Pcsa. Real-time updates on events, politics, business and more.
February 1, 2024
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Free Report) CEO George K. Ng purchased 10,000 shares of Processa Pharmaceuticals stock in a transaction that occurred on Tuesday, January 30th. The stock was acquired at an average price of $2.70 per share, with a total value of $27,000.00. Following the transaction, the chief executive officer now owns […]
January 19, 2024
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Free Report) shares are going to reverse split before the market opens on Monday, January 22nd. The 1-20 reverse split was announced on Monday, January 22nd. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, January 22nd. Processa Pharmaceuticals Stock Down 25.3 % […]
January 19, 2024
Shares of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Free Report) are set to reverse split before the market opens on Monday, January 22nd. The 1-20 reverse split was announced on Monday, January 22nd. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, January 22nd. Processa Pharmaceuticals Stock Performance NASDAQ […]
January 1, 2024
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Free Report) was the recipient of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 303,000 shares, a decrease of 17.6% from the November 30th total of 367,800 shares. Based on an average daily volume of 2,400,000 shares, […]
November 29, 2023
HANOVER, MD, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage...
November 21, 2023
Maxim Group reissued their hold rating on shares of Processa Pharmaceuticals (NASDAQ:PCSA – Free Report) in a research note issued to investors on Friday, Benzinga reports. Processa Pharmaceuticals Stock Performance Shares of PCSA stock opened at $0.42 on Friday. The stock has a market cap of $10.46 million, a price-to-earnings ratio of -0.37 and a […]
November 17, 2023
Processa Pharmaceuticals (NASDAQ:PCSA – Get Free Report)‘s stock had its “hold” rating reissued by investment analysts at Maxim Group in a note issued to investors on Friday, Benzinga reports. Processa Pharmaceuticals Trading Up 1.0 % Shares of NASDAQ PCSA traded up $0.00 during midday trading on Friday, reaching $0.42. 476,549 shares of the company were […]
November 13, 2023
Hanover, MD., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) announced today with great sadness that Virgil Thompson,...
July 29, 2023
Processa Pharmaceuticals (NASDAQ:PCSA – Get Free Report) and BetterLife Pharma (OTCMKTS:BETRF – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, valuation, risk, analyst recommendations and institutional ownership. Earnings & Valuation This table compares Processa […]
June 1, 2023
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) shares shot up 2.6% during mid-day trading on Tuesday . The company traded as high as $0.57 and last traded at $0.56. 35,908 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 201,922 shares. The stock had previously closed at $0.55. […]